Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study.
Figen Öztürk ErgürMurat YıldızMelahat Uzel ŞenerSuna KavurgacıAyperi ÖztürkPublished in: Sao Paulo medical journal = Revista paulista de medicina (2022)
In this study, it was determined that favipiravir may constitute an alternative for treating COVID-19 pneumonia given that its side effects are generally well tolerated and not serious.